Investment in diabetes-focused AI companies exceeds $361 million in 2023
Investments in diabetes-focused AI companies have reached $361.6 million in 2023, according to a new report by Aging Analytics Agency, a UK-based market intelligence agency focused on longevity analysis and a subsidiary of Deep Knowledge Group. The influx of financial support is a testament to the transformative ...